| Substance use during pregnancy A Forray F1000Research 5, 2016 | 410 | 2016 |
| Pregnant women with posttraumatic stress disorder and risk of preterm birth KA Yonkers, MV Smith, A Forray, CN Epperson, D Costello, H Lin, ... JAMA psychiatry 71 (8), 897-904, 2014 | 249 | 2014 |
| Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period A Forray, M Focseneanu, B Pittman, CJ McDougle, CN Epperson The Journal of clinical psychiatry 71 (8), 13337, 2010 | 225 | 2010 |
| Substance use in the perinatal period A Forray, D Foster Current psychiatry reports 17, 1-11, 2015 | 194 | 2015 |
| Perinatal substance use: a prospective evaluation of abstinence and relapse A Forray, B Merry, H Lin, JP Ruger, KA Yonkers Drug and alcohol dependence 150, 147-155, 2015 | 193 | 2015 |
| Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? KA Yonkers, N Gotman, MV Smith, A Forray, K Belanger, WL Brunetto, ... Epidemiology 22 (6), 848-854, 2011 | 158 | 2011 |
| Antidepressant use in pregnant and postpartum women KA Yonkers, KA Blackwell, J Glover, A Forray Annual review of clinical psychology 10 (1), 369-392, 2014 | 144 | 2014 |
| Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes KA Yonkers, K Gilstad-Hayden, A Forray, HS Lipkind JAMA psychiatry 74 (11), 1145-1152, 2017 | 138 | 2017 |
| Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scale KA Yonkers, N Gotman, T Kershaw, A Forray, HB Howell, BJ Rounsaville Obstetrics & Gynecology 116 (4), 827-833, 2010 | 107 | 2010 |
| Prevalence of post-traumatic stress disorder in pregnant women with prior pregnancy complications A Forray, LC Mayes, U Magriples, CN Epperson The Journal of Maternal-Fetal & Neonatal Medicine 22 (6), 522-527, 2009 | 87 | 2009 |
| The use of electroconvulsive therapy in postpartum affective disorders A Forray, RB Ostroff The Journal of ECT 23 (3), 188-193, 2007 | 84 | 2007 |
| Future pharmacological treatments for substance use disorders A Forray, M Sofuoglu British Journal of Clinical Pharmacology 77 (2), 382-400, 2014 | 79 | 2014 |
| A randomized controlled trial of screening and brief interventions for substance misuse in reproductive health S Martino, SJ Ondersma, A Forray, TA Olmstead, K Gilstad-Hayden, ... American journal of obstetrics and gynecology 218 (3), 322. e1-322. e12, 2018 | 70 | 2018 |
| Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and … KA Yonkers, A Forray, HB Howell, N Gotman, T Kershaw, BJ Rounsaville, ... General Hospital Psychiatry 34 (5), 439-449, 2012 | 60 | 2012 |
| Opioid use in pregnancy AL Tobon, E Habecker, A Forray Current Psychiatry Reports 21, 1-10, 2019 | 58 | 2019 |
| Progesterone for the reduction of cocaine use in post-partum women with a cocaine use disorder: a randomised, double-blind, placebo-controlled, pilot study KA Yonkers, A Forray, C Nich, KM Carroll, C Hine, BC Merry, H Shaw, ... The Lancet Psychiatry 1 (5), 360-367, 2014 | 57 | 2014 |
| Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the … LM Fucito, MP Bars, A Forray, AM Rojewski, S Shiffman, P Selby, R West, ... nicotine & tobacco research 16 (7), 909-914, 2014 | 46 | 2014 |
| The collision of mental health, substance use disorder, and suicide A Forray, KA Yonkers Obstetrics & Gynecology 137 (6), 1083-1090, 2021 | 37 | 2021 |
| Marijuana use in adults living with sickle cell disease JD Roberts, J Spodick, J Cole, J Bozzo, S Curtis, A Forray Cannabis and cannabinoid research 3 (1), 162-165, 2018 | 36 | 2018 |
| Progesterone for smoking relapse prevention following delivery: a pilot, randomized, double-blind study A Forray, K Gilstad-Hayden, C Suppies, D Bogen, M Sofuoglu, ... Psychoneuroendocrinology 86, 96-103, 2017 | 28 | 2017 |
